9-(2-萘基)蒽
|
N398303-100g
|
≥98% |
7424-72-8 |
100g
|
¥ 9990.9
|
现货 |
阿拉丁 |
多沙唑嗪
|
D334301-100mg
|
Moligand™, ≥98% |
74191-85-8 |
100mg
|
¥ 618.9
|
现货 |
阿拉丁 |
2-(4-甲氧苯基)吡咯烷
|
M158431-5g
|
≥98% |
74190-66-2 |
5g
|
¥ 3999.9
|
现货 |
阿拉丁 |
2-(4-甲氧苯基)吡咯烷
|
M158431-250mg
|
≥98% |
74190-66-2 |
250mg
|
¥ 499.9
|
现货 |
阿拉丁 |
甲氨蝶呤二钠盐
|
M338754-5g
|
≥98% |
7413-34-5 |
5g
|
¥ 119.9
|
现货 |
阿拉丁 |
甲氨蝶呤二钠盐
|
M338754-25g
|
≥98% |
7413-34-5 |
25g
|
¥ 403.9
|
现货 |
阿拉丁 |
甲氨蝶呤二钠盐
|
M338754-100g
|
≥98% |
7413-34-5 |
100g
|
¥ 1438.9
|
现货 |
阿拉丁 |
5a(S),10b(R)-5a,10b-二氢-2-(五氟苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑并[4,,3-D][1,4]醇四氟硼酸恶嗪
|
N300511-1g
|
≥95% |
740816-14-2 |
1g
|
¥ 1857.9
|
现货 |
阿拉丁 |
5a(S),10b(R)-5a,10b-二氢-2-(五氟苯基)-4H,6H-茚并[2,1-b][1,2,4]三唑并[4,,3-D][1,4]醇四氟硼酸恶嗪
|
N300511-100mg
|
≥95% |
740816-14-2 |
100mg
|
¥ 217.9
|
现货 |
阿拉丁 |
氟哌啶醇癸酸酯
|
H345251-50mg
|
≥98% |
74050-97-8 |
50mg
|
¥ 4428.9
|
现货 |
阿拉丁 |
氟哌啶醇癸酸酯
|
H345251-25mg
|
≥98% |
74050-97-8 |
25mg
|
¥ 2409.9
|
现货 |
阿拉丁 |
氟哌啶醇癸酸酯
|
H345251-10mg
|
≥98% |
74050-97-8 |
10mg
|
¥ 1204.9
|
现货 |
阿拉丁 |
氟哌啶醇癸酸酯
|
H345251-100mg
|
≥98% |
74050-97-8 |
100mg
|
¥ 6487.9
|
现货 |
阿拉丁 |
阿拉格列汀
|
A413364-50mg
|
Moligand™, ≥97% |
739366-20-2 |
50mg
|
¥ 6951.9
|
现货 |
阿拉丁 |
3,5-双(三氟甲基)苯硼酸(含有数量不等的酸酐)
|
B104538-100g
|
≥97% |
73852-19-4 |
100g
|
¥ 529.9
|
现货 |
阿拉丁 |
甲环素磺基水杨酸盐
|
M134011-5mg
|
≥95% |
73816-42-9 |
5mg
|
¥ 350.9
|
现货 |
阿拉丁 |
甲环素磺基水杨酸盐
|
M134011-50mg
|
≥95% |
73816-42-9 |
50mg
|
¥ 1441.9
|
现货 |
阿拉丁 |
甲环素磺基水杨酸盐
|
M134011-25mg
|
≥95% |
73816-42-9 |
25mg
|
¥ 833.9
|
现货 |
阿拉丁 |
甲环素磺基水杨酸盐
|
M134011-10mg
|
≥95% |
73816-42-9 |
10mg
|
¥ 514.9
|
现货 |
阿拉丁 |
瑞卢戈利
|
R413337-25mg
|
Moligand™, ≥98% |
737789-87-6 |
25mg
|
¥ 376.9
|
现货 |
阿拉丁 |
瑞卢戈利
|
R413337-250mg
|
Moligand™, ≥98% |
737789-87-6 |
250mg
|
¥ 2054.9
|
现货 |
阿拉丁 |
瑞卢戈利
|
R413337-100mg
|
Moligand™, ≥98% |
737789-87-6 |
100mg
|
¥ 845.9
|
现货 |
阿拉丁 |
氧化前胡素
|
O414374-5mg
|
≥98% |
737-52-0 |
5mg
|
¥ 247.9
|
现货 |
阿拉丁 |
氧化前胡素
|
O414374-25mg
|
≥98% |
737-52-0 |
25mg
|
¥ 642.9
|
现货 |
阿拉丁 |